Explore GallantU: free, RACE-approved CE for veterinary professionals

Healing from Within: The Synergy of Nutrition and Stem Cell Therapy References

by Rebecca Windsor DVM, DACVIM
  1. Spitznagel MB, Gober MW, Patrick K. Caregiver burden in cat owners: a cross-sectional observational study. Journal of Feline Medicine and Surgery. 2023;25(1):1098612X221145835. doi:10.1177/1098612X221145835
  2. Spitznagel MB, Jacobson DM, Cox MD, Carlson MD. Caregiver burden in owners of a sick companion animal: a cross‐sectional observational study. Veterinary Record. 2017;181(12):321-321. doi:10.1136/vr.104295
  3. Li WH, Yuan XY, Wang Z, Lin R. Nutrient sensing in intestinal stem cell: Linking dietary nutrients to cellular metabolic regulation. World J Stem Cells. 2025;17(7). doi:10.4252/wjsc.v17.i7.107770
  4. Mana MD, Kuo EYS, Yilmaz ÖH. Dietary Regulation of Adult Stem Cells. Curr Stem Cell Rep. 2017;3(1):1-8. doi:10.1007/s40778-017-0072-x
  5. Andersen OE, Poulsen JV, Farup J, De Morree A. Regulation of adult stem cell function by ketone bodies. Front Cell Dev Biol. 2023;11:1246998. doi:10.3389/fcell.2023.1246998
  6. Puca F, Fedele M, Rasio D, Battista S. Role of Diet in Stem and Cancer Stem Cells. Int J Mol Sci. 2022;23(15):8108. doi:10.3390/ijms23158108
  7. Schönberger K, Cabezas-Wallscheid N. How nutrition regulates hematopoietic stem cell features. Experimental Hematology. 2023;128:10-18. doi:10.1016/j.exphem.2023.09.008
  8. Barthez M, Song Z, Wang CL, Chen D. Stem Cell Metabolism and Diet. Curr Stem Cell Rep. 2020;6(4):119-125. doi:10.1007/s40778-020-00180-4
  9. Novak JSS, Baksh SC, Fuchs E. Dietary interventions as regulators of stem cell behavior in homeostasis and disease. Genes Dev. 2021;35(3-4):199-211. doi:10.1101/gad.346973.120
  10. Kot M, Bronowicka-Adamska P, Tyszka-Czochara M. Regulation of Human Stem Cells by Functional Food Components: How Vitamins, Minerals and Phytochemicals Influence Mesenchymal Stem Cells’ Fate and Function. Nutrients. 2025;17(22):3548. doi:10.3390/nu17223548
  11. Levental KR, Surma MA, Skinkle AD, et al. ω-3 polyunsaturated fatty acids direct differentiation of the membrane phenotype in mesenchymal stem cells to potentiate osteogenesis. Sci Adv. 2017;3(11):eaao1193. doi:10.1126/sciadv.aao1193
  12. Ji Y, Yang Y, Wu Z. Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome. Microbial Pathogenesis. 2023;185:106436. doi:10.1016/j.micpath.2023.106436
  13. Hooper LV, Littman DR, Macpherson AJ. Interactions Between the Microbiota and the Immune System. Science. 2012;336(6086):1268-1273. doi:10.1126/science.1223490
  14. O’Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF. The gut microbiota-immune-brain axis: Therapeutic implications. Cell Reports Medicine. 2025;6(3):101982. doi:10.1016/j.xcrm.2025.101982
  15. Park JC, Chang L, Kwon HK, Im SH. Beyond the gut: decoding the gut–immune–brain axis in health and disease. Cell Mol Immunol. 2025;22(11):1287-1312. doi:10.1038/s41423-025-01333-3
  16. Suchodolski JS. COMPANION ANIMALS SYMPOSIUM: Microbes and gastrointestinal health of dogs and cats1. Journal of Animal Science. 2011;89(5):1520-1530. doi:10.2527/jas.2010-3377
  17. Wang Q, Meng Q, Chen Y, et al. Interaction between gut microbiota and immunity in health and intestinal disease. Front Immunol. 2025;16:1673852. doi:10.3389/fimmu.2025.1673852
  18. Yang B, Zhong S, Wang J, Yu W. Dietary Modulation of the Gut Microbiota in Dogs and Cats and Its Role in Disease Management. Microorganisms. 2025;13(12):2669. doi:10.3390/microorganisms13122669
  19. Ziese AL, Suchodolski JS. Impact of Changes in Gastrointestinal Microbiota in Canine and Feline Digestive Diseases. Veterinary Clinics of North America: Small Animal Practice. 2021;51(1):155-169. doi:10.1016/j.cvsm.2020.09.004
  20. Liu Y, Wang J, Wu C. Modulation of Gut Microbiota and Immune System by Probiotics, Pre-biotics, and Post-biotics. Front Nutr. 2022;8:634897. doi:10.3389/fnut.2021.634897
  21. Li P, Wu G. Amino acid nutrition and metabolism in domestic cats and dogs. J Animal Sci Biotechnol. 2023;14(1):19. doi:10.1186/s40104-022-00827-8
  22. Verbrugghe A, Bakovic M. Peculiarities of One-Carbon Metabolism in the Strict Carnivorous Cat and the Role in Feline Hepatic Lipidosis. Nutrients. 2013;5(7):2811-2835. doi:10.3390/nu5072811
  23. Calder PC. n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition. 2006;83(6):1505S-1519S. doi:10.1093/ajcn/83.6.1505S
  24. Barroso C, Fonseca AJM, Cabrita ARJ. Vitamins, Minerals and Phytonutrients as Modulators of Canine Immune Function: A Literature Review. Veterinary Sciences. 2024;11(12):655. doi:10.3390/vetsci11120655
  25. Titmarsh H, Gow AG, Kilpatrick S, et al. Association of Vitamin D Status and Clinical Outcome in Dogs with a Chronic Enteropathy. J Vet Intern Med. 2015;29(6):1473-1478. doi:10.1111/jvim.13603
  26. Kather S, Grützner N, Kook PH, Dengler F, Heilmann RM. Review of cobalamin status and disorders of cobalamin metabolism in dogs. Journal of Veterinary Internal Medicine. 2020;34(1):13-28. doi:10.1111/jvim.15638
  27. Cheng CW, Biton M, Haber AL, et al. Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet. Cell. 2019;178(5):1115-1131.e15. doi:10.1016/j.cell.2019.07.048
  28. Mihaylova MM, Cheng CW, Cao AQ, et al. Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging. Cell Stem Cell. 2018;22(5):769-778.e4. doi:10.1016/j.stem.2018.04.001
  29. Duangprom S, Kheolamai P, Tantrawatpan C, Manochantr S. High glucose inhibits proliferation, migration, and osteogenic differentiation of human placenta-derived mesenchymal stem cells. Sci Rep. 2025;15(1):22512. doi:10.1038/s41598-025-06454-3
  30. Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis. Osteoporos Int. 2013;24(5):1647-1661. doi:10.1007/s00198-012-2138-z
  31. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446-450. doi:10.1038/nature12721
  32. Gorabi AM, Kiaie N, Hajighasemi S, Jamialahmadi T, Majeed M, Sahebkar A. The Effect of Curcumin on the Differentiation of Mesenchymal Stem Cells into Mesodermal Lineage. Molecules. 2019;24(22):4029. doi:10.3390/molecules24224029
  33. Wu J, Ge Y, Huang W, et al. Natural bioactive compounds modified with mesenchymal stem cells: new hope for regenerative medicine. Front Bioeng Biotechnol. 2025;13:1446537. doi:10.3389/fbioe.2025.1446537
  34. Johnson KA, Lee AH, Swanson KS. Nutrition and nutraceuticals in the changing management of osteoarthritis for dogs and cats. javma. 2020;256(12):1335-1341. doi:10.2460/javma.256.12.1335
  35. Barbeau-Grégoire M, Otis C, Cournoyer A, Moreau M, Lussier B, Troncy E. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. IJMS. 2022;23(18):18. doi:10.3390/ijms231810384
  36. Roush JK, Cross AR, Renberg WC, et al. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. javma. 2010;236(1):67-73. doi:10.2460/javma.236.1.67
  37. Roush JK, Dodd CE, Fritsch DA, et al. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. javma. 2010;236(1):59-66. doi:10.2460/javma.236.1.59
  38. Fritsch D, Allen TA, Dodd CE, et al. Dose-Titration Effects of Fish Oil in Osteoarthritic Dogs: Fatty Acid-Responsive Osteoarthritis. Journal of Veterinary Internal Medicine. 2010;24(5):5. doi:10.1111/j.1939-1676.2010.0572.x
  39. Fritsch DA, Allen TA, Dodd CE, et al. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. javma. 2010;236(5):535-539. doi:10.2460/javma.236.5.535
  40. Corbee RJ, Barnier MMC, Van De Lest CHA, Hazewinkel HAW. The effect of dietary long‐chain omega‐3 fatty acid supplementation on owner’s perception of behaviour and locomotion in cats with naturally occurring osteoarthritis. Animal Physiology Nutrition. 2013;97(5):5. doi:10.1111/j.1439-0396.2012.01329.x
  41. Lascelles BDX, DePuy V, Thomson A, et al. Evaluation of a Therapeutic Diet for Feline Degenerative Joint Disease: Feline DJD Diet. Journal of Veterinary Internal Medicine. 2010;24(3):3. doi:10.1111/j.1939-1676.2010.0495.x
  42. Corbee RJ. The efficacy of a nutritional supplement containing green‐lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. Veterinary Medicine & Sci. 2022;8(3):3. doi:10.1002/vms3.779
  43. Eason C, Adams S, Puddick J, et al. GreenshellTM Mussels: A Review of Veterinary Trials and Future Research Directions. Veterinary Sciences. 2018;5(2):36. doi:10.3390/vetsci5020036
  44. Rialland P, Bichot S, Lussier B, et al. Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis. Can J Vet Res. 2013;77(1):66-74.
  45. Kampa N, Kaenkangploo D, Jitpean S, et al. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial. Front Vet Sci. 2023;10:1033188. doi:10.3389/fvets.2023.1033188
  46. Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Veterinary Record. 2003;152(11):323-329. doi:10.1136/vr.152.11.323
  47. Gupta RC, Canerdy TD, Lindley J, et al. Comparative therapeutic efficacy and safety of type‐II collagen (uc‐II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate. Animal Physiology Nutrition. 2012;96(5):5. doi:10.1111/j.1439-0396.2011.01166.x
  48. Stabile M, Fracassi L, Lacitignola L, et al. Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study. Hoque A, ed. PLoS ONE. 2024;19(10):e0305697. doi:10.1371/journal.pone.0305697
  49. Blees NR, Teunissen M, Dobenecker B, Prawitt J, Tryfonidou MA, Jan Corbee R. Collagen Hydrolysates as Nutritional Support in Canine Osteoarthritis: A Narrative Review. Animal Physiology Nutrition. 2025;109(2):590-600. doi:10.1111/jpn.14076
  50. Dobenecker B, Böswald LF, Reese S, et al. The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients—A translational large animal model for a nutritional therapy option. Tomaszewska E, ed. PLoS ONE. 2024;19(9):e0308378. doi:10.1371/journal.pone.0308378
  51. Martello E, Bigliati M, Adami R, et al. Efficacy of a dietary supplement in dogs with osteoarthritis: A randomized placebo-controlled, double-blind clinical trial. Abuelo A, ed. PLoS ONE. 2022;17(2):e0263971. doi:10.1371/journal.pone.0263971
  52. Comblain F, Barthélémy N, Lefèbvre M, et al. A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis. BMC Vet Res. 2017;13(1):395. doi:10.1186/s12917-017-1317-8
  53. Lefort-Holguin M, Delsart A, Otis C, et al. Efficacy and Safety of a Diet Enriched with EPA and DHA, Turmeric Extract and Hydrolysed Collagen in Management of Naturally Occurring Osteoarthritis in Cats: A Prospective, Randomised, Blinded, Placebo- and Time-Controlled Study. Animals. 2024;14(22):22. doi:10.3390/ani14223298
  54. Liu A, Liang X, Wang W, et al. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis. Stem Cell Res Ther. 2023;14(1):271. doi:10.1186/s13287-023-03471-9
  55. Wang H, Sun Y, Xiao FJ, et al. Mesenchymal Stem Cells Ameliorate DSS-Induced Experimental Colitis by Modulating the Gut Microbiota and MUC-1 Pathway. JIR. 2023;Volume 16:2023-2039. doi:10.2147/JIR.S402592
  56. Ocansey DKW, Wang L, Wang J, et al. Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clinical & Translational Med. 2019;8(1):e31. doi:10.1186/s40169-019-0251-8
  57. Liu A, Li C, Wang C, Liang X, Zhang X. Impact of Mesenchymal Stem Cells on the Gut Microbiota and MicrobiotaAssociated Functions in Inflammatory Bowel Disease: A SystematicReview of Preclinical Evidence on Animal Models. CSCR. 2024;19(7):981-992. doi:10.2174/011574888X250413230920051715
  58. Bensignor E, Morgan DM, Nuttall T. Efficacy of an essential fatty acid‐enriched diet in managing canine atopic dermatitis: a randomized, single‐blinded, cross‐over study. Veterinary Dermatology. 2008;19(3):156-162. doi:10.1111/j.1365-3164.2008.00670.x
  59. Olivry T, Marsella R, Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective? Veterinary Immunology and Immunopathology. 2001;81(3-4):347-362. doi:10.1016/S0165-2427(01)00316-6
  60. Eisenschenk MNC. The Role of Diet, Nutrition, and Supplements in Canine Atopic Dermatitis. Veterinary Clinics of North America: Small Animal Practice. 2025;55(2):189-198. doi:10.1016/j.cvsm.2024.11.003
  61. Watson A, Laxalde J, Martini F, Fischer N, Maina E, Favrot C. Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6‐Month Randomised, Blinded, Controlled, Clinical Trial. Veterinary Dermatology. 2026;37(1):89-102. doi:10.1111/vde.70017
  62. Watson A, Rostaher A, Fischer NM, Favrot C. A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine‐month controlled study. Veterinary Dermatology. 2022;33(1):55. doi:10.1111/vde.13020
  63. De Santiago MS, Arribas JLG, Llamas YM, Becvarova I, Meyer H. Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis. BMC Vet Res. 2021;17(1):354. doi:10.1186/s12917-021-03063-w
  64. Van Amersfort K, Van Der Lee A, Hagen‐Plantinga E. Evidence‐base for the beneficial effect of nutraceuticals in canine dermatological immune‐mediated inflammatory diseases — A literature review. Veterinary Dermatology. 2023;34(4):266-283. doi:10.1111/vde.13152
  65. Noli C, Varina A, Barbieri C, Pirola A, Olivero D. Analysis of Intestinal Microbiota and Metabolic Pathways before and after a 2-Month-Long Hydrolyzed Fish and Rice Starch Hypoallergenic Diet Trial in Pruritic Dogs. Veterinary Sciences. 2023;10(7):478. doi:10.3390/vetsci10070478
  66. Guidi EEA, Gramenzi A, Persico P, Di Prinzio R, Di Simone D, Cornegliani L. Effects of Feeding a Hypoallergenic Diet with a Nutraceutical on Fecal Dysbiosis Index and Clinical Manifestations of Canine Atopic Dermatitis. Animals. 2021;11(10):2985. doi:10.3390/ani11102985
  67. Swain S, Sahoo P, Biswal S, Sethy K, Panda AN, Sahoo N. Fecal bacterial microbiota diversity characterized for dogs with atopic dermatitis: its alteration and clinical recovery after meat-exclusion diet. ajvr. 2025;86(5):ajvr.24.09.0274. doi:10.2460/ajvr.24.09.0274
  68. Lagoa T, Martins L, Queiroga MC. Microbiota Modulation as an Approach to Prevent the Use of Antimicrobials Associated with Canine Atopic Dermatitis. Biomedicines. 2025;13(10):2372. doi:10.3390/biomedicines13102372
  69. Elliott J, Rawlings JM, Markwell PJ, Barber PJ. Survival of cats with naturally occurring chronic renal failure: effect of dietary management. J of Small Animal Practice. 2000;41(6):235-242. doi:10.1111/j.1748-5827.2000.tb03932.x
  70. Plantinga EA, Everts H, Kastelein AMC, Beynen AC. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Veterinary Record. 2005;157(7):185-187. doi:10.1136/vr.157.7.185
  71. Ross SJ, Osborne CA, Kirk CA, Lowry SR, Koehler LA, Polzin DJ. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. javma. 2006;229(6):949-957. doi:10.2460/javma.229.6.949
  72. Wang Y, Luo P, Wuren T. Narrative Review of Mesenchymal Stem Cell Therapy in Renal Diseases: Mechanisms, Clinical Applications, and Future Directions. Rahman MS, ed. Stem Cells International. 2024;2024(1):8658246. doi:10.1155/sci/8658246
  73. Chen F, Chen N, Xia C, et al. Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges. Cell Transplant. 2023;32:09636897231164251. doi:10.1177/09636897231164251
  74. Quimby JM, Webb TL, Gibbons DS, Dow SW. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: A pilot study. Journal of Feline Medicine and Surgery. 2011;13(6):6. doi:10.1016/j.jfms.2011.01.005
  75. Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther. 2013;4(2):2. doi:10.1186/scrt198
  76. Quimby JM, Webb TL, Randall E, Marolf A, Valdes-Martinez A, Dow SW. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats. Journal of Feline Medicine and Surgery. 2016;18(2):2. doi:10.1177/1098612X15576980
  77. Song Y, Liu Y, Yu Y, et al. Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease. Front Vet Sci. 2025;12:1632324. doi:10.3389/fvets.2025.1632324
  78. Thomson AL, Berent AC, Weisse C, Langston CE. Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial. J Vet Intern Med. 2019;33(3):3. doi:10.1111/jvim.15486
  79. Zacharias S, Welty MB, Sand TT, Black LL. Impact of allogeneic feline uterine-derived mesenchymal stromal cell intravenous treatment on renal function of nephrectomized cats with chronic kidney disease. Research in Veterinary Science. 2021;141:33-41. doi:10.1016/j.rvsc.2021.09.015
  80. Lv Y, Hua Z, Lu X. Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis. Front Pharmacol. 2025;15:1511525. doi:10.3389/fphar.2024.1511525
  81. Luo Y, Xiao X. Effects and safety analysis of diets with different Omega-3:Omega-6 ratios on postoperative recovery indicators in cats with feline chronic gingivostomatitis (FCGS). The Veterinary Journal. 2026;318:106765. doi:10.1016/j.tvjl.2026.106765
  82. Anderson JG, Rojas CA, Scarsella E, et al. The Oral Microbiome across Oral Sites in Cats with Chronic Gingivostomatitis, Periodontal Disease, and Tooth Resorption Compared with Healthy Cats. Animals. 2023;13(22):22. doi:10.3390/ani13223544
  83. Williams VS, Schneider JL, Parrish RS, et al. Clinical field study evaluating the safety and efficacy of allogeneic uterine-derived mesenchymal stem cells for refractory feline chronic gingivostomatitis. Journal of Feline Medicine and Surgery. 2025;27(11):1098612X251385852. doi:10.1177/1098612X251385852
  84. Williams VS, Schneider JL, Parrish RS, et al. Long-term field safety study evaluating allogeneic, uterine-derived mesenchymal stem cells for refractory feline chronic gingivostomatitis. Journal of Feline Medicine and Surgery. 2026;28(4):1098612X261431058. doi:10.1177/1098612X261431058
  85. Arzi B, Clark KC, Sundaram A, et al. Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis. Stem Cells Translational Medicine. 2017;6(8):8. doi:10.1002/sctm.17-0035
  86. Arzi B, Mills-Ko E, Verstraete FJM, et al. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Translational Medicine. 2016;5(1):1. doi:10.5966/sctm.2015-0127
  87. Soltero-Rivera M, Hart S, Blandino A, Vapniarsky N, Arzi B. Mesenchymal stromal cell therapy for feline chronic gingivostomatitis: Long term experience. Front Vet Sci. 2023;10:1171922. doi:10.3389/fvets.2023.1171922
  88. Febre M, Maddens S, Robert C, Rakic R, Plantier N, Saulnier N. Single infusion of allogeneic neonatal Mesenchymal stromal cells to manage refractory feline gingivostomatitis- A clinical pilot study. Cytotherapy. 2020;22(5):5. doi:10.1016/j.jcyt.2020.03.182
  89. Febre M, Saulnier N, Roux P, et al. Placenta‐derived mesenchymal stromal cells as a treatment for refractory chronic gingivostomatitis in cats: eight cases (2018). J of Small Animal Practice. 2023;64(4):4. doi:10.1111/jsap.13583
  90. Teshima T, Yasumura Y, Suzuki R, Matsumoto H. Antiviral Effects of Adipose Tissue-Derived Mesenchymal Stem Cells Secretome against Feline Calicivirus and Feline Herpesvirus Type 1. Viruses. 2022;14(8):8. doi:10.3390/v14081687
  91. Taechangam N, Walker NJ, Borjesson DL. Feline adipose-derived mesenchymal stem cells induce effector phenotype and enhance cytolytic function of CD8+ T cells. Stem Cell Res Ther. 2021;12(1):1. doi:10.1186/s13287-021-02558-5
  92. Taechangam N, Iyer SS, Walker NJ, Arzi B, Borjesson DL. Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation. Stem Cell Res Ther. 2019;10(1):188. doi:10.1186/s13287-019-1300-3Williams ZJ, Pezzanite LM, Chow L, Rockow M, Dow SW. Evaluation of stem-cell therapies in companion animal disease models: a concise review (2015-2023). Stem Cells. 2024;42(8):677-705. doi:10.1093/stmcls/sxae034
Rebecca Windsor DVM, DACVIM
Rebecca Windsor DVM, DACVIM

Vice President of Veterinary Affairs at Gallant

Dr. Rebecca Windsor, DVM, DACVIM, is a board-certified veterinary neurologist with over 20 years of clinical experience and a strong record of scientific publication. She joined Gallant in 2025 and serves as Vice President of Veterinary Affairs.

Dr. Windsor specializes in veterinary regenerative medicine, with a focus on advancing FDA-approved, off-the-shelf mesenchymal stem cell therapies for pets. She develops educational platforms that translate the science, safety, and clinical efficacy of stem cell therapy for veterinary professionals. Since 2019, she has served as a Clinician Scientist at Ethos Discovery, where she leads the neurology research portfolio.

Related Articles

Treating Earlier and Aging Better: Expanding Options for Osteoarthritis References
Read more
AVMA 2026 Proceedings References
Read more
Western Veterinary Conference Proceedings References
Read more

Gallant is redefining veterinary medicine with ready-to-use stem cell therapies that reduce inflammation, restore function, and fit seamlessly into everyday practice.

Connect with us
Stay in Touch

Subscribe for thoughtful updates on clinical trials, product development, and the future of regenerative pet care.

About Gallant
For Veterinarians
For Pet Parents
Science & Insights
AAHA Logo
© 2019-2026 Gallant. All Rights Reserved. 
Terms & Conditions. Privacy Policy. Copyright & Cookies. Consent Preferences. Do Not Sell or Share My Personal Information.